Rahul Sarugaser
Stock Analyst at Raymond James
(0.03)
# 4,401
Out of 4,829 analysts
10
Total ratings
12.5%
Success rate
-27.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rahul Sarugaser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Initiates: Outperform | $3 | $0.52 | +477.81% | 1 | Apr 4, 2024 | |
| QIPT Quipt Home Medical | Downgrades: Market Perform | $10 | $2.18 | +358.72% | 1 | Feb 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Market Perform | $100 | $7.76 | +1,188.66% | 4 | Nov 15, 2023 | |
| PROF Profound Medical | Downgrades: Outperform | n/a | $4.63 | - | 2 | Aug 4, 2023 | |
| VFF Village Farms International | Downgrades: Market Perform | $11 → $2.5 | $0.67 | +274.76% | 2 | Feb 27, 2023 |
Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $0.52
Upside: +477.81%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $2.18
Upside: +358.72%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $100
Current: $7.76
Upside: +1,188.66%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $4.63
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11 → $2.5
Current: $0.67
Upside: +274.76%